Clinical Faculty Bio

Andrew_Goldsweig-cardovascular-2017-web.jpgAndrew Goldsweig, M.D., FACC
Associate Medical Director of Structural Heart Disease
Assistant Professor, Internal Medicine
Division of Cardiovascular Medicine

Academic office:
982265 Nebraska Medical Center
Omaha, NE 68198-2265
Phone (402)559-5151
Fax (402)559-8355

Clinic Practice Location:
Durham Outpatient Center
For Appointments Call (402)559-8888
Toll Free 1-800-97-HEART (1-800-974-3278)

Hospital Appointments:
The Nebraska Medical Center 

Board Certification:
Interventional Cardiology
Cardiovascular Disease
Internal Medicine
Cardiac CT
Nuclear Cardiology
Peripheral Vascular Ultrasound

2016 -2017 Brown University – Structural Heart Disease & Advanced Peripheral Intervention Fellowship
Academic Appointment: Instructor & Attending Interventional Cardiologist, Brown Medical School
Procedures: TAVR, MitraClip, ASD/PFO/VSD Closure, Valvuloplasty, Atrial Appendage Closure

2015-2016 Yale New Haven Hospital – Interventional Cardiology Fellowship, Coronary & Peripheral
Procedures: Atherectomy Devices, Crossing Devices, Impella, CTO PCI, Biopsy, Alcohol Septal Ablation

2012-2015 Yale New Haven Hospital – Cardiovascular Diseases Fellowship
Teaching: Yale PA School Cardiovascular Seminar Leader 2015
Additional Clinic: Adult Congenital Heart Disease 2014 – 2015

2009-2012 Yale New Haven Hospital – Internal Medicine Residency
Leadership: Resident Representative on Primary Care Center Staff Committee
Award: Johnson & Johnson Global Health Scholar – Rwanda 6-8/2011

2003-2009 New York University School of Medicine – MD, Alpha Omega Alpha Honor Society, “Honors” in every rotation
Teaching: Medical Microbiology Teaching Assistant 2007
Graduate Courses: Molecular Bio 1 & 2, Adv Genetics, NIH Research Ethics, Med Journal Seminar

1999-2003 Massachusetts Institute of Technology – BS Chemistry, BS Biology, National Merit Scholar

Selected Publications:

Goldsweig AM, et al. “Carotid Artery Interventions – Endarterectomy, Stenting, and Neuroprotection.”
CathSAP 5. American College of Cardiology. Invited chapter. In press.

Goldsweig AM, et al. “Physician and Patient Radiation Exposure During Endovascular Procedures.” Current
Treatment Options in Cardiovascular Medicine. In press. Accepted 2016 November 16.

Sardar MR, Goldsweig AM, et al. “Vascular Complications Associated with Transcatheter Aortic Valve
Replacement.” Vascular Medicine. Invited Review. In press.

Kolte D, Khera S, Sardar MR, Gheewala N, Gupta T, Chatterjee S, Goldsweig AM, et al. “Thirty-Day
Readmissions After Transcatheter Aortic Valve Replacement in the United States: Insights from the
Nationwide Readmissions Database.” Circ Cardiovasc Interv. In press. Accepted 2016 November 14.

Goldsweig AM. “Bypassing a Bypass: A Case of Transcatheter Aortic Valve Replacement and Percutaneous
Closure of a Regurgitant Apical-Aortic Conduit.” J Cardiovasc Surg. In press. Accepted 2016 May 10.

Goldsweig AM, et al. “Tools of the Trade: Adjunctive Tools for Lesion Crossing in Critical Limb Ischemia.”
Med Equip Insights. 2015. 6: 1-5.

Goldsweig AM, et al. “A Balloon-Expandable Sheath Facilitates Transfemoral TAVR in Patients with
Peripheral Vascular Disease and Tortuosity.” Ther Adv Cardiovasc Dis. 2015 Mar 16. 1-8.

Goldsweig AM, et al. “Contemporary Use of Dual Antiplatelet Therapy for Preventing Cardiovascular Events.”
Am J Manag Care. 2014. 20 (8): 659-65.

Wall SP, Kwon N, Goldsweig A, et al. “Derivation of the Organ Donation Belief Index Using Modern Test
Theory.” Acad Emerg Med. 2010. 17 (Supplement 1): S62.

Goldsweig AM. “Confluent and Reticulated Papillomatosis.” Consult Peds. 2009. 8 (12): 432.

Goldsweig AM. “Married to My Work.” The Legible Script. U South Florida. 2008. 11-3.

Pihasov A, Mandel S, Torchinsky A, Giladi E, Pitel Z, Goldsweig AM, et al. “Activity-dependent
neuroprotective protein: a novel gene essential for brain formation.” Dev Brain Res. 2003. 144 (1): 83-90.

Peterson ML, Morissette SL, McNulty C, Goldsweig AM, et al. “Iterative high-throughput polymorphism
studies on acetaminophen and an experimentally derived structure for form III.” J Am Chem Soc. 2002. 124
(37): 10958-9.

Pinhasov A, Goldsweig AM, et al. “Activity-dependent neuroprotective protein gene expression is
developmentally regulated.” Neural Plast. 2001. 8 (3): 193-4.